InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-6.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Leibowitz Arthur S, Directeur. Director active across 1 company, notably Organogenesis Holdings Inc.. In total, 8 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €25k. Activity tracked since 3 August 2021. The latest transaction was filed on 9 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Leibowitz Arthur S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
5,000 股@ US$2.68145.7% 占其流量Class A Common StockSEC:0002064832-26-000129:0
标准退出：2026年6月7日 (T+90)
48,828 股0Class A Common StockSEC:0002064832-26-000054:0
49,575 股0Class A Common StockSEC:0001062993-25-003217:0
51,020 股0Class A Common StockSEC:0001062993-24-004306:0
65,737 股0Class A Common StockSEC:0001062993-23-004881:0
3,000 股@ US$4.755100.0% 占其流量Class A Common StockSEC:0001062993-22-018040:0
标准退出：2022年11月10日 (T+90)
20,547 股0Class A Common StockSEC:0001062993-22-004806:0
5,000 股0Class A Common StockSEC:0001661181-21-000064:0
8 条申报中的 8 条
About Leibowitz Arthur S
Leibowitz Arthur S is Director at Organogenesis Holdings Inc. He has 8 filings in total, and across the sampled recent filings, cumulative purchases are EUR 25460 and sales are EUR 0, between 2021-08-05 and 2026-03-11. The most frequent transaction nature is Attribution.
